The rating affirmation affects $480 million of CHLA’s debt.
The rating affirmation was supported by a number of factors, including the hospital’s stable core operating performance, positive reputation, and strong brand name.
CHLA also faces some challenges, which were considered for the rating affirmation, such as the irregular timing and nature of revenue from the California provider fee program as well as the financial strain of supporting a large research program.
More articles on healthcare finance:
Moody’s revises Mercy Health’s outlook to negative
Fitch assigns ‘AA-‘ rating to WellSpan Health’s bonds
Moody’s affirms Holy Name Medical Center’s ‘Baa2’ rating
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
